Synergy Pharmaceuticals Inc $3.63

down -0.14


28/7/2014 05:20 PM  |  NASDAQ : SGYP  
Industries : Drugs / Drug Manufacturers - Other
Get Trend Analysis Icon Get SGYP Trend Analysis - it has underperformed the S&P 500 by 36%

Partner Headlines

  1. US Stock Futures Down; Alcoa Earnings In Focus

    Benzinga
  2. Small Pharmaceuticals Rallying Following FDA Report

    Benzinga
  3. Benzinga's Top #PreMarket Gainers

    Benzinga
  4. US Stock Futures Edge Higher Ahead Of Durable-Goods Orders Data

    Benzinga
  5. Synergy Pharmaceuticals Closes Enrollment for Phase 2b Plecanatide Trial ...

    Benzinga
  6. UPDATE: Aegis Capital Reiterates on Synergy Pharmaceuticals on Approaching ...

    Benzinga
  7. Synergy Pharmaceuticals Initiates Phase 3 Clinical Trial of Plecanatide ...

    Benzinga
  8. US Stock Futures Down Ahead Of Jobless Claims Data

    Benzinga
  9. Synergy Initiates Phase 2 Study of SP-333

    Benzinga
  10. US Stock Futures Down; ADP Report In Focus

    Benzinga
  11. Synergy Pharmaceuticals to Initiate Phase 2 Study of SP-333 for Opioid-Induced ...

    Benzinga
  12. Synergy Pharmaceuticals to Spin-Off FV-100 Assets

    Benzinga
  13. Synergy Pharmaceuticals, Inc. (SGYP) Chairman Gabriel Cerrone buys 5,0 ...

    GuruFocus
  14. Synergy Pharmaceuticals, Inc. (SGYP) Chairman Gabriel Cerrone buys 13, ...

    GuruFocus
  15. A Peek Into The Market Before The Trading Starts

    Benzinga
  16. Synergy Pharmaceuticals Initiates Phase I Clinical trial of SP-333 for ...

    Benzinga
  17. Synergy Pharmaceuticals Shareholders Approve Merger with Callisto Pharmaceuticals

    Benzinga
  18. Stocks Soar on Fiscal Cliff Deal; Dow Climbs More Than 300 Points

    Benzinga
  19. UPDATE: Canaccord Genuity Raises PT to $10 on Synergy Pharmaceuticals on ...

    Benzinga
  20. Benzinga's Top Pre-Market Gainers

    Benzinga
  21. Synergy Reports Positive Phase IIb/III Trial Results for Plecanatide in ...

    Benzinga
  22. Aegis Capital Reiterates Buy Rating, $25 PT on Synergy Pharmaceuticals

    Benzinga
  23. A Peek Into The Market Before The Trading Starts

    Benzinga
  24. Synergy Pharmaceuticals Completes Phase I Trial of SP-333 to Treat Gastrointestinal ...

    Benzinga
  25. A Peek Into The Market Before The Trading Starts

    Benzinga
  26. Synergy Begins Phase IIb Trial of Plecanatide for IBS-C

    Benzinga
  27. UPDATE: Canaccord Genuity Initiates Synergy Pharmaceuticals at Buy on Opportunities

    Benzinga
  28. Synergy Pharma Files IND for Gastro Diseases Drug

    Benzinga
  29. LyondellBasell Industries, BP Prudhoe Bay Royalty Included in Stocks Up ...

    FoxBusiness
  30. Synergy Pharma Buys FV-100 Drug from Bristol-Myers

    Benzinga
  31. Low-Priced Small-Caps That Won't Stay That Way

    Benzinga
  32. Synergy Pharmaceuticals Announces Exercise of Remainder of Over-Allotment ...

    Benzinga
  33. Synergy Pharmaceuticals Announces Partial Exercise of Over-Allotment Option ...

    Benzinga
  34. European Patent Office Upholds Synergy Pharmaceuticals' Grant of Claims ...

    Benzinga
Trading Center